CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.
Management will participate in 1×1 meetings on Wednesday, February 14th. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.
CONTACT: Investor Inquiries: ICR Westwicke Mike Piccinino, CFA OrganoIR@westwicke.com Press and Media Inquiries: Organogenesis communications@organo.com
SAN DIEGO, CA / ACCESSWIRE / June 11, 2024 / For those afflicted by substance…
Between Us Clinic Survey Reveals Urologists' Top ED Treatment Recommendations: Diet, Exercise, and Mindfulness Meditation…
Company earns recertification, validating commitment to strong cybersecurity protecting sensitive dataBALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems…
Annual User Conference and Innovation Challenge Designed to Pioneer the Future of Digital Health and…
Company earns recertification, validating commitment to strong cybersecurity protecting sensitive dataBALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems…
Annual User Conference and Innovation Challenge Designed to Pioneer the Future of Digital Health and…